The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: cephalexin     Quarter: 2016Q3

   |<   1/2   << Previous Page   Page 2   Next Page >>   1/2   >|       Skip To

Total Records: 172     Number of Pages: 9

DRUGNAME PT EventCount
Cephalexin capsules USP 500mg Lip swelling 2
Cephalexin capsules USP 500mg Rash papular 2
CEPHALEXIN MONOHYDRATE. Anaemia 2
CEPHALEXIN MONOHYDRATE. Arthropathy 2
CEPHALEXIN MONOHYDRATE. Knee arthroplasty 2
CEPHALEXIN MONOHYDRATE. Oropharyngeal pain 2
CEPHALEXIN MONOHYDRATE. Urinary tract infection 2
CEPHALEXIN. Arthralgia 2
CEPHALEXIN. Arthritis bacterial 2
CEPHALEXIN. Blood pressure decreased 2
CEPHALEXIN. Blood pressure fluctuation 2
CEPHALEXIN. Blood pressure increased 2
CEPHALEXIN. Body temperature decreased 2
CEPHALEXIN. Cataract 2
CEPHALEXIN. Diabetes mellitus 2
CEPHALEXIN. Drug clearance decreased 2
CEPHALEXIN. Gingival pain 2
CEPHALEXIN. Haemoglobin increased 2
CEPHALEXIN. Hair colour changes 2
CEPHALEXIN. Hypersensitivity 2

   |<   1/2   << Previous Page   Page 2   Next Page >>   1/2   >|       Skip To

Total Records: 172     Number of Pages: 9

Execution Time: 0.042305946350098 seconds (ucode:5307670). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and Global Public Data.